These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26478895)

  • 1. Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease.
    Buddhala C; Loftin SK; Kuley BM; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
    Ann Clin Transl Neurol; 2015 Oct; 2(10):949-59. PubMed ID: 26478895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms?
    Jellinger KA
    J Neural Transm Suppl; 1999; 56():1-29. PubMed ID: 10370901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological substrates of mental dysfunction in Lewy body disease: an update.
    Jellinger KA
    J Neural Transm Suppl; 2000; 59():185-212. PubMed ID: 10961431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying regional α -synuclein, amyloid β, and tau accumulation in lewy body dementia.
    Miller RL; Dhavale DD; O'Shea JY; Andruska KM; Liu J; Franklin EE; Buddhala C; Loftin SK; Cirrito JR; Perrin RJ; Cairns NJ; Campbell MC; Perlmutter JS; Kotzbauer PT
    Ann Clin Transl Neurol; 2022 Feb; 9(2):106-121. PubMed ID: 35060360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
    Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exendin-4 reverses biochemical and behavioral deficits in a pre-motor rodent model of Parkinson's disease with combined noradrenergic and serotonergic lesions.
    Rampersaud N; Harkavyi A; Giordano G; Lever R; Whitton J; Whitton PS
    Neuropeptides; 2012 Oct; 46(5):183-93. PubMed ID: 22921965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.
    Jellinger KA
    Mol Chem Neuropathol; 1991 Jun; 14(3):153-97. PubMed ID: 1958262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded α-synuclein inclusions.
    Stoyka LE; Arrant AE; Thrasher DR; Russell DL; Freire J; Mahoney CL; Narayanan A; Dib AG; Standaert DG; Volpicelli-Daley LA
    Neurobiol Dis; 2020 Feb; 134():104708. PubMed ID: 31837424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors.
    Hall H; Jewett M; Landeck N; Nilsson N; Schagerlöf U; Leanza G; Kirik D
    PLoS One; 2013; 8(5):e64844. PubMed ID: 23705016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease.
    Hall H; Reyes S; Landeck N; Bye C; Leanza G; Double K; Thompson L; Halliday G; Kirik D
    Brain; 2014 Sep; 137(Pt 9):2493-508. PubMed ID: 25062696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction and dementia in Parkinson's disease.
    Bosboom JL; Stoffers D; Wolters ECh
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1303-15. PubMed ID: 15480840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compensatory neuritogenesis of serotonergic afferents within the striatum of a transgenic rat model of Parkinson's disease.
    Stemick J; Gauer C; Wihan J; Moceri S; Xiang W; von Hörsten S; Kohl Z; Winkler J
    Brain Res; 2020 Dec; 1748():147119. PubMed ID: 32919983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and development of Lewy pathology: a critical update.
    Jellinger KA
    J Neurol; 2009 Aug; 256 Suppl 3():270-9. PubMed ID: 19711116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Locus Coeruleus Pathology with Nigral and Forebrain Pathology in Parkinson's Disease.
    Huynh B; Fu Y; Kirik D; Shine JM; Halliday GM
    Mov Disord; 2021 Sep; 36(9):2085-2093. PubMed ID: 33899954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study.
    Wilson H; Dervenoulas G; Pagano G; Koros C; Yousaf T; Picillo M; Polychronis S; Simitsi A; Giordano B; Chappell Z; Corcoran B; Stamelou M; Gunn RN; Pellecchia MT; Rabiner EA; Barone P; Stefanis L; Politis M
    Lancet Neurol; 2019 Aug; 18(8):748-759. PubMed ID: 31229470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.
    Cheshire P; Ayton S; Bertram KL; Ling H; Li A; McLean C; Halliday GM; O'Sullivan SS; Revesz T; Finkelstein DI; Storey E; Williams DR
    Mov Disord; 2015 May; 30(6):796-804. PubMed ID: 25649148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
    Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delusions and visual hallucinations in a patient with Parkinson's disease with dementia showing pronounced Lewy body pathology in the nucleus basalis of Meynert.
    Sakai K; Ikeda T; Ishida C; Komai K; Yamada M
    Neuropathology; 2019 Aug; 39(4):319-323. PubMed ID: 31243794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging in Parkinson's disease: the role of monoamines in behavior.
    Brooks DJ; Piccini P
    Biol Psychiatry; 2006 May; 59(10):908-18. PubMed ID: 16581032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.